New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 1, 2013
09:04 EDTTSLA, NTT, SNE, NMR, VRNG, CLF, UAL, BCRX, PC, KWK, STM, RT, EBAY, AM, HMCOn The Fly: Pre-market Movers
HIGHER: Tesla (TSLA), up 13.5% after announcing Model S sales exceeded its target, saying it expects to be profitable in Q1... American Greetings (AM), up 12.4%, agrees to be acquired by Weiss family for $18.35 per share... Quicksilver (KWK), up 18.7% after selling 25% interest in Barnett Shale assets... BioCryst (BCRX), up 30%, after saying FDA outlined pathway by which company could file NDA seeking approval of intravenous peramivir... Vringo (VRNG), up 9.8% after announcing suit filed against ZTE... Cliffs Natural (CLF), up 3.4% after being added to Analyst Focus list at JPMorgan... eBay (EBAY), up 2.6% after upgrade at Canaccord, several price target increases after company's analyst day meeting on Thursday... Ruby Tuesday (RT), up 6.7%, STMicroelectronics (STM), up 4% following positive mentions in Barron's... LOWER: United Continental (UAL), down 3.2% after downgrade at Evercore... SEVERAL JAPANESE STOCKS LOWER: Panasonic (PC), down 5.2%, after WSJ says company investigated for alleged bribery by U.S., company confirms intent to delist from NYSE on April 22, general weakness in Japanese stocks. Shares of several other Japanese companies trading in New York lower after Nikkei index closed down over 2% following the Bank of Japan's quarterly Tankan survey showing confidence among large Japanese manufacturers saw a only a modest uptick. Names trading lower include Nomura (NMR), Sony (SNE), Nippon Telegraph and Telephone (NTT), and Honda (HMC).
News For TSLA;AM;EBAY;RT;STM;KWK;PC;BCRX;UAL;CLF;VRNG;NMR;SNE;NTT;HMC From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | all recent news | >>
October 12, 2014
19:26 EDTBCRXPatient being evaluated at Boston hospital for possible Ebola, Boston Globe says
Health officials say that a man that recently traveled to Liberia is being assessed at Beth Israel Deaconess hospital in Boston for the Ebola virus, the Boston Globe says. Drug companies that are working on experimental Ebola treatments include Tekmira (TKMR), Sarepta (SRPT), BioCryst (BCRX), Chimerix (CMRX) and NewLink Genetics (NLNK). Reference Link
19:12 EDTBCRXCDC confirms Texas healthcare worker positive for Ebola
Subscribe for More Information
17:21 EDTTSLATesla ahead of other car makers on semiautonomous driving system, WSJ says
Subscribe for More Information
14:18 EDTBCRXNY's JFK Airport begins Ebola screenings, WSJ says
Subscribe for More Information
12:48 EDTBCRXTexas health-care worker tests positive for Ebola, WSJ says
Subscribe for More Information
October 10, 2014
17:14 EDTTSLAMarket ends week lower amid global growth worries
Subscribe for More Information
16:02 EDTTSLAActionable Options for Friday, October, 10
Subscribe for More Information
15:58 EDTTSLATesla breaks support, levels to watch
Shares are ending near session lows, last at $236.76. Support is at the session low at $235.20. Resistance is at previous support at $238.49.
15:42 EDTUALPlane held on Las Vegas tarmac over Ebola scare, Reuters reports
Subscribe for More Information
15:27 EDTCLFCliffs held preliminary talks on iron ore assets with Glencore, WSJ says
Glencore had talks that were described as "very preliminary" with Cliffs Natural Resources about its Australian iron ore assets, according to The Wall Street Journal, citing people familiar with the matter. Shares of Cliffs spiked higher following the first headlines from the report, but are now down about 1% in late afternoon trading. Reference Link
15:16 EDTCLFCliffs Natural held preliminary talks on iron ore assets with Glencore, DJ says
12:52 EDTTSLATesla shares sink after all-wheel drive model unveiling
Shares of Tesla (TSLA) are falling after the company's CEO, Elon Musk, introduced an all-wheel drive model and some autonomous driving features on a number of its vehicles. On October 2, Musk had teased on Twitter that Tesla would "unveil D, something else,' exciting investors. WHAT'S NEW: Musk last night said Tesla would enable consumers to buy an all-wheel drive version of the company's Model S electric vehicle. The all wheel drive feature will increase the speed and efficiency of vehicles, Musk said. It will also enable the cars to drive more effectively in poor driving conditions, the CEO stated. The feature will be offered on the company's new advanced Model S car, the P85D, which will cost $120,000. The feature can be added onto other Tesla vehicles for $4,000. Additionally, Musk announced that all new Model S vehicles will have a number of auto pilot features. Among other capabilities, the new vehicles will be able to change lanes and park on their own, the CEO said. ANALYST REACTION: The updates unveiled by Tesla largely add features already offered by other companies, Merrill Lynch analyst John Lovallo II wrote For example, Mercedes has been offering all wheel drive since 1985, and Subaru offers the technology as a standard feature on almost all of its vehicles, Lovallo stated. Several companies also offer the speed limit reading feature, the analyst reported. Tesla's ability to drive its share price up at will, exhibited by the rise in the stock following Musk's tweet, could create a significant risk for shareholders, the analyst warned. He kept an Underperform rating on the name. WHAT’S NOTABLE: Shares of Mobileye (MBLY), which develops components for automatic driver-assist systems, are falling today. Mobileye investors may be disappointed that Tesla did not offer more advanced autonomous driving features. PRICE ACTION: In early afternoon trading, Tesla slumped 6% to $242 and Mobileye sank 7% to $50.50.
10:54 EDTBCRXMapp looking to up production of experimental Ebola treatment, WSJ says
Mapp Biopharmaceutical is aiming to broaden the manufacturing of its experimental Ebola treatment, ZMapp, according to The Wall Street Journal, citing comments from the company. Mapp said that the treatment was given to a few infected individuals prior to supplies running out two months ago. Drug companies that are working on experimental Ebola treatments include Tekmira (TKMR), Sarepta (SRPT), BioCryst (BCRX), Chimerix (CMRX) and NewLink Genetics (NLNK). Reference Link
10:04 EDTEBAYXoom could be a acquisition of target of PayPal, says Monness Crespi
Subscribe for More Information
09:57 EDTTSLATesla drops after 'D' announcement, levels to watch
The shares are down over 6% to $241. At that price next support is at $240.24 and then at $238.49. Resistance is at $245.26.
09:21 EDTTSLATesla's announcement may fail to impress investors, says BofA/Merrill
Subscribe for More Information
09:00 EDTTSLAOn The Fly: Pre-market Movers
Subscribe for More Information
07:04 EDTSNEAmazon in talks to join digital locker for movies. WSJ reports
Subscribe for More Information
06:14 EDTTSLATesla unveils all-wheel-drive version of Model S
Subscribe for More Information
06:00 EDTEBAYStocks with implied volatility below IV index mean; GPS EBAY
Subscribe for More Information
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use